An update on genetic, structural and functional studies of arylamine N-acetyltransferases in eucaryotes and procaryotes

Human Molecular Genetics

Volumn 9, Issue 16 REV. ISS., 2000, Pages 2435-2441

  Sim, Edith ^a   Payton, Mark ^a   Noble, Martin ^b   Minchin, Rodney ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2 FLUORENYLAMINE; 4 AMINOBENZOIC ACID; ACETYL COENZYME A; AMINOSALICYLIC ACID; AROMATIC AMINE; ARYLAMINE ACETYLTRANSFERASE; ASPARTIC ACID; BACTERIAL ENZYME; CARCINOGEN; CYSTEINE; DAPSONE; ENZYME ANTIBODY; FOLIC ACID; GENE PRODUCT; GLUTAMIC ACID DERIVATIVE; HISTIDINE; HYDRAZINE; ISOENZYME; ISONIAZID; NITROGEN; PROCAINAMIDE; SULFADIMIDINE; SULFONAMIDE; TUBERCULOSTATIC AGENT;

ACETYLATION; AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; CATALYSIS; CONTROLLED STUDY; DRUG INACTIVATION; DRUG METABOLISM; EMBRYO; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME LOCALIZATION; ENZYME MECHANISM; ENZYME STRUCTURE; EUKARYOTIC CELL; FETUS; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; INTESTINE; LIVER; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NEURAL TUBE; NONHUMAN; PHARMACOGENETICS; PRIORITY JOURNAL; PROKARYOSIS; PROTEIN EXPRESSION; REVIEW; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; STRUCTURE ANALYSIS;

ANIMALIA; BACTERIA (MICROORGANISMS); EUKARYOTA; MAMMALIA; MURINAE; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; POSIBACTERIA; PROKARYOTA;

EID: 0033759301     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/9.16.2435     Document Type: Review

References (91)

1. Interethnic factors affects drug response
2. Pharmacogenomics: Into the new millennium
3. Studies on the metabolic basis for the genetically determined capacities for isoniazid inactivation in man
4. Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Interim report: No activity of isoniazid in the continuation phase
5. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
6. Cloning and characterization of arylamine N-acetyltransferase genes from Mycobacterium tuberculosis: Increased expression results in isoniazid resistance
7. Peripheral neuritis due to isoniazid
8. Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis
9. The role of N-acetyltransferase phenotypes on bladder carcinogenesis: A pharmacogenetic epidemiological approach to bladder cancer
10. Slow acetylation is a susceptibility factor in occupational and smoking related bladder cancer
11. N-acetyltransferase genetics and their role in predisposition to aromatic and heterocyclic amine-induced carcinogenesis
12. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms and breast cancer risk
13. Breast cancer, heterocyclic aromatic amines from meat and N-acetyltransferase 2 genotype
14. Variants of N-acetyltransferase NAT1 and a case control study of colorectal carcinomas
15. N-Acetyltransferase polymorphisms and colorectal cancer: A HuGE review
16. International collaborative study on genetic susceptibility to environmental carcinogens
17. Human arylamine N-acetyltransferase genes: Isolation, chromosomal localisation and functional expression
18. Cloning and expression of cDNAs for polymorphic and monomorphic arylamine N-acetyltransferases of human liver
19. Arylamine N-acetyltransferases
20. Enzyme kinetic properties of human recombinant arylamine N-acetyltransferase 2 allotypic variants expressed in Eschericia coli
21. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases
22. Partial purification and properties of the isoniazid transacetylase in human liver: Its relationship to the acetylation of p-amino-salicylic acid
23. The role of xenobiotic metabolizing enzymes in arylamine toxicity and carcinogenesis: Functional and localization studies
24. Expression of monomorphic and polymorphic N-acetyltransferases in human colon
25. Expression of arylamine N-acetyltransferase in human intestine
26. N-acetyltransferase expression and metabolic activation of the food-derived heterocyclic amines in the human mammary gland
27. Expression of N-acetyltransferase (NAT) in cultured human uroepithelial cells
28. Expression of monomorphic arylamine N-acetyltransferase (NAT1) in human leukocytes
29. Arylamine N-acetyltransferase in erythrocytes of cystic fibrosis patients
30. Identification and characterization of variant alleles of human acetyltransferase NAT1 with defective function using p-aminosalicylate as an in-vivo and in-vitro probe
31. Individual variability in p-aminobenzoic acid acetylation by human N-acetyltransferase (NAT1) of peripheral blood
32. Acetylation of p-aminobenzoylglutamate, a folic acid catabolite, by recombinant human arylamine N-acetyltransferase and U937 cells
33. Purification of recombinant human N-acetyltransferase type 1 expressed in E. coli and characterisation of its potential role in folate metabolism
34. Folate catabolism is increased during pregnancy in rats
35. Accelerated folate breakdown in pregnancy
36. Functional polymorphism of the human arylamine N-acetyltransferase type 1 gene caused by C190T and G560A mutations
37. Correlation between genotype and phenotype of the human arylamine N-acetyltransferase type 1 (NAT 1)
38. Genotyping human arylamine N-acetyltransferase type 1 (NAT1): The identification of two novel allelic variants
39. Isolation and mapping of a cosmid clone containing the human NAT2 gene
40. Chromosomal localisation of human genes for arylamine N-acetyltransferase
41. Mapping AAC1, AAC2 and AACP, the genes for arylamine N-acetyltransferase, carcinogen metabolising enzymes on human chromosome 8p22, a region frequently deleted in tumours
42. Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms
43. Genes for human arylamine N-acetyltransferases in relation to loss of the short arm of chromosome 8 in bladder cancer
44. Detailed physical and deletion mapping of 8p with isolation of YAC clones from tumour suppressor loci involved in colorectal cancer
45. Arylamine N-acetyltransferase type 2 (NAT2), chromosome 8 aneuploidy, and identification of a novel NAT1 cosmid clone: An investigation in bladder cancer by interphase FISH
46. Update on consensus arylamine N-acetyltransferase gene nomenclature
47. Placental expression of arylamine N-acetyltransferase: Evidence for linkage disequilibrium between NAT1*10 and NAT2*4 alleles of the two human arylamine N-acetyltransferase loci NAT1 and NAT2
48. Association of arylamine N-acetyltransferases NAT1 and NAT2 genotypes to laryngeal cancer risk
49. Correlation between acetylator phenotypes and genotypes of polymorphic arylamine N-acetyltransferase in human liver
50. Molecular mechanism of slow acetylation of drugs and carcinogens in humans
51. N-acetyltransferase polymorphism. Comparison of genotype and phenotype
52. Physiology and molecular biology of arylamine N-acetyltransferases
53. Novel N-acetyltransferase 2 alleles that differ in mechanism for slow acetylator phenotype
54. N-acetyltransferase 1: Two polymorphisms in coding sequence identified in colorectal cancer patients
55. Polymorphism in the N-acetyltransferase 1 (NAT1) polyadenylation signal: Association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue
56. Substrate-dependent regulation of human arylamine N-acetyltransferase-1 in cultured cells
57. Immunochemical detection of arylamine N-acetyltransferase in normal and neoplastic bladder
58. Acetyltransferases in humans: Development and tissue distribution
59. Oxidative biotransformations of 2-acetylaminofluorenein fetal and placental tissues of humans and monkeys: Correlation with arylhydrocarbon hydroxylase activities
60. Arylamine N-acetyltransferase activity of the human placenta
61. Expression of arylamine N-acetyltransferases in pre-term placentas and in human pre-implantation embryos
62. Arylamine N-acetyltransferase in Balb/c mice: Identification of a novel mouse isoenzyme by cloning and expression in vitro
63. Linkage of Nat and Es-1 in the mouse and development of strains congenic for N-acetyltransferase
64. Chromosomal localisation and mapping of the genes for murine arylamine N-acetyltransferases (NATs), enzymes involved in the metabolism of carcinogens: Identification of a novel non-coding exon for Nat2
65. A method for genotyping murine arylamine N-acetyltransferase type 2 (NAT2): A gene expressed in preimplantation embryonic stem cells encoding an enzyme acetylating the folate catabolite p-aminobenzoylglutamate
66. Molecular genetic basis of rapid and slow acetylation in mice
67. Cloning, sequencing, and recombinant expression of Natl, Nat2, and Nat3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: Functional characterisation of the activation and deactivation of carcinogens
68. Localization of polymorphic N-acetyltransferase (NAT2) in tissues of inbred mice
69. Immunochemical detection of arylamine N-acetyltransferase during mouse embryonic development and in adult mouse brain
70. Developmental expression of N-acetyltransferases in C57BI/6 mice
71. Prevention of neural tube defects: Results of the MRC vitamin study
72. Role of acetyltransferases in the metabolism and carcinogenicity of aromatic amines
73. Investigation of N-acetyltransferase (NAT1) in Alzheimer's disease: Identification of a novel NAT1 allelic variant
74. Major effects on teratogen-induced facial clefting in mice determined by a single genetic region
75. Folate and oral clefts: Where do we go from here? New directions in oral clefts research
76. Involvement of cys 69 in the catalytic mechanism of NhoA of Salmonella typhimurium
77. Identification of arylamine N-acetyltransferase like sequences in procaryotes
78. Functional characterization of arylamine N-acetyltransferases in bacteria
79. Characterisation of the KatG gene encoding catalase-peroxidase required for the isoniazid susceptibility of Mycobacterium tuberculusis
80. Genome and MIC stability in Mycobacterium tuberculosis and indications for continuation of use of isoniazid in multi-drug resistant tuberculosis
81. Polymorphisms of mycobacterial arylamine N-acetyltransferases may lead to structural change
82. Structure-function studies of human Arylamine N-acetyltransferases NAT1 and NAT2
83. Study of the role of the highly conserved residues Arg(9) and Arg(64) in the catalytic function of human N-acetyltransferases NAT1 and NAT2 by site-directed mutagenesis
84. A fragment consisting of the first 204 amino acids of NAT1 and the first transacetylation step of catalysis
85. Purification, characterization and crystallisation of an N-hydroxyarylamine O-acetyltransferase from Salmonella typhimurium
86. Contribution to activity of histidine-aromatic, amide-aromatic, and aromatic-aromatic interactions in the extended catalytic site of cysteine proteinases
87. Overexpression and large-scale purification of recombinant hamster polymorphic arylamine N-acetyltransferase as a dihydrofolate reductase fusion protein
88. 1995 IRBM workshop team Update on protein structure prediction: Results of the 1995 workshop